UBS Group’s Molecular Data Inc. American Depositary Shares MKD Stock Holding History

UBS Group’s Portfolio MKD Stock Details MKD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-45,505	Closed	-$26K	–	11833
2022 Q2	$26K	Buy	45,505 +42,994	+1,712%	+$61.9K	﹤0.01%	6585
2022 Q1	$8K	Sell	2,511 -2,643	-51%	-$7.38K	﹤0.01%	8778
2021 Q4	$17K	Buy	5,154 +4,297	+501%	+$19.9K	﹤0.01%	8130
2021 Q3	$4K	Buy	857 +199	+30%	+$1.64K	﹤0.01%	8770
2021 Q2	$9K	Sell	658 -698	-51%	-$9.29K	﹤0.01%	8198
2021 Q1	$22K	Buy	1,356 +622	+85%	+$11.6K	﹤0.01%	7319
2020 Q4	$9K	Buy	734 +447	+156%	+$7.32K	﹤0.01%	7593
2020 Q3	$5K	Buy	287 +77	+37%	+$2.11K	﹤0.01%	7363
2020 Q2	$9K	Buy	+210	New	+$5.88K	﹤0.01%	7112

Other funds holding MKD

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

UBS Group's MKD Position: Q3 2022 in Review

UBS Group sold out of Molecular Data Inc. American Depositary Shares (MKD) in Q3 2022, closing a stake of 45,505 shares — an estimated $26K sold.

UBS Group first reported a position in MKD in Q2 2020 and held it in 9 quarters. The position peaked at $26K in Q2 2022. 2 funds tracked by Wall St. Rank hold MKD as of Q3 2022.

UBS Group reported no remaining Molecular Data Inc. American Depositary Shares position as of Q3 2022 after selling out during the quarter.
UBS Group sold 45,505 Molecular Data Inc. American Depositary Shares shares in Q3 2022, an estimated $26K.
UBS Group first reported a position in Molecular Data Inc. American Depositary Shares in Q2 2020 and held it in 9 quarters.
UBS Group's Molecular Data Inc. American Depositary Shares position peaked at $26K in Q2 2022.
2 funds tracked by Wall St. Rank held Molecular Data Inc. American Depositary Shares as of Q3 2022.

Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.